التفاصيل البيبلوغرافية
| العنوان: |
Hereditary epidermolytic palmoplantar keratosis due to a novel desmoglein‐1 mutation: A case report. |
| المؤلفون: |
Koschitzki, Kevin, Kurz, Bernadett, Schreml, Julia, Fischer, Judith, Hotz, Alrun, Hammers, Christoph M., Berneburg, Mark, Niebel, Dennis, Schreml, Stephan |
| المصدر: |
Clinical Case Reports; May2024, Vol. 12 Issue 5, p1-5, 5p |
| مصطلحات موضوعية: |
KERATOSIS, GENETIC mutation, RETINOIDS, PHOTOTHERAPY |
| مستخلص: |
Key Clinical Message: Keratosis palmoplantaris striata type I (SPPK‐I) is a rare autosomal‐dominant type of hereditary epidermolytic palmoplantar keratoderma, which can be caused by mutations in desmoglein‐1 (DSG‐1). Patients suffer from hyperkeratotic plaques and painful palmoplantar fissures. Unfortunately, treatment options including salicylic vaseline, topical corticosteroids, phototherapy, and retinoids are inefficient. Hereditary palmoplantar keratodermas (PPKs) represent a heterogeneous group of rare skin disorders with epidermal palmoplantar hyperkeratosis. Mutations in the desmoglein 1 gene (DSG1), a transmembrane glycoprotein, have been reported primarily in striate PPKs. We report a patient with keratosis palmoplantaris striata type I (SPPK‐I) with a specific pathogenic variant [c.349C>T, p.(Arg117*)] in DSG1. Despite increased understanding, effective treatment options for PPK, including SPPK‐I, remain limited. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Case Reports is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder